IRE1/JNK Is the Leading UPR Pathway in 6-OHDA-Induced Degeneration of Differentiated SH-SY5Y Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25147679 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Natalia Siwecka und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, Mazowiecka 5, 92-215 Lodz, Poland. Hauptthemen laut MEDLINE: eIF-2 Kinase, Endoplasmic Reticulum Stress, Endoribonucleases, Oxidopamine. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, Medical University of Lodz, National Science Centre, Poland.
Abstract (Originalsprache)
Parkinson’s disease (PD) is a neurodegenerative disorder which affects dopaminergic neurons of the midbrain. Accumulation of α-synuclein or exposure to neurotoxins like 6-hydroxydopamine (6-OHDA) induces endoplasmic reticulum (ER) stress along with the unfolded protein response (UPR), which executes apoptosis via activation of PERK/CHOP or IRE1/JNK signaling. The present study aimed to determine which of these pathways is a major contributor to neurodegeneration in an 6-OHDA-induced in vitro model of PD. For this purpose, we have applied pharmacological PERK and JNK inhibitors (AMG44 and JNK V) in differentiated SH-SY5Y cells exposed to 6-OHDA. Inhibition of PERK and JNK significantly decreased genotoxicity and improved mitochondrial respiration, but only JNK inhibition significantly increased cell viability. Gene expression analysis revealed that the effect of JNK inhibition was dependent on a decrease in MAPK10 and XBP1 mRNA levels, whereas inhibition of either PERK or JNK significantly reduced the expression of DDIT3 mRNA. Western blot has shown that JNK inhibition strongly induced the XBP1s protein, and inhibition of each pathway attenuated the phosphorylation of eIF2α and JNK, as well as the expression of CHOP. Collectively, our data suggests that targeting the IRE1/JNK pathway of the UPR is a more effective option for PD treatment as it simultaneously affects more than one pro-apoptotic pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, Mazowiecka 5, 92-215 Lodz, Poland.
ORCID-Profile: Natalia Siwecka, Grzegorz Galita, Zuzanna Granek, Wojciech Wiese, Wioletta Rozpędek-Kamińska
Förderung
- National Science Center
- Medical University of Lodz
- National Science Centre, Poland
- Medical University of Lodz, Poland
Zitieren
APA
Siwecka, N., Galita, G., Granek, Z., Wiese, W., Majsterek, I., & Rozpędek-Kamińska, W. (2024). IRE1/JNK Is the Leading UPR Pathway in 6-OHDA-Induced Degeneration of Differentiated SH-SY5Y Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25147679
Vancouver
Siwecka N, Galita G, Granek Z, Wiese W, Majsterek I, Rozpędek-Kamińska W. IRE1/JNK Is the Leading UPR Pathway in 6-OHDA-Induced Degeneration of Differentiated SH-SY5Y Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25147679
BibTeX
@article{Siwecka2024,
author = {Siwecka, Natalia and Galita, Grzegorz and Granek, Zuzanna and Wiese, Wojciech and Majsterek, Ireneusz and Rozpędek-Kamińska, Wioletta},
title = {IRE1/JNK Is the Leading UPR Pathway in 6-OHDA-Induced Degeneration of Differentiated SH-SY5Y Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25147679}
}
EUVIMED